This binding disrupts WTAP-methyltransferase-like protein 3 (METTL3)–methyltransferase-like protein 14 (METTL14) complex formation, reducing overall m6A modification in tumor cells, inhibiting HCC cell growth [220]. The gene discussed is METTL14; the disease is neoplasm.